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Glycosomes are membrane-bounded microbody organelles that compartmentalize glycolysis as well as other
important metabolic processes in trypanosomatids. The compartmentalization of these enzymatic reactions is
hypothesized to play a crucial role in parasite physiology. Although the metabolic role of glycosomes differs
substantially from that of the peroxisomes that are found in other eukaryotes, similarities in signals targeting
proteins to these organelles suggest that glycosomes and peroxisomes may have evolved from a common
ancestor. To examine this hypothesis, as well as gain insights into the function of the glycosome, we used a
positive genetic selection procedure to isolate the first Leishmania mutant (gim1-1 [glycosome import] mutant)
with a defect in the import of glycosomal proteins. The mutant retains glycosomes but mislocalizes a subset
glycosomal proteins to the cytoplasm. Unexpectedly, the gim1-1 mutant lacks lipid bodies, suggesting a
heretofore unknown role of the glycosome. We used genetic approaches to identify a gene, GIM1, that is able
to restore import and lipid bodies. A nonsense mutation was found in one allele of this gene in the mutant line.
The predicted Gim1 protein is related the peroxin 2 family of integral membrane proteins, which are required
for peroxisome biogenesis. The similarities in sequence and function provide strong support for the common
origin model of glycosomes and peroxisomes. The novel phenotype of gim1-1 and distinctive role of Leishmania
glycosomes suggest that future studies of this system will provide a new perspective on microbody biogenesis
and function.

of plants (8, 40). However, glycosomes perform many functions
that peroxisomes do not. For example, the enzymes involved in
glucose metabolism and nucleic acid synthesis that are glycosomal in kinetoplastids are cytoplasmic, not peroxisomal, in
other organisms. At least some enzymes involved in ether-lipid
synthesis (19) and b-oxidation of fatty acids (21, 28) occur in
both glycosomes and peroxisomes.
Intriguing evidence for an evolutionary relationship between
glycosomes and peroxisomes has come from the determination
of the signals which target proteins to their matrices. At least
two types of targeting signals directing proteins to peroxisomes
and glycosomes are related at the sequence level. The type 1
peroxisomal targeting signal, a C-terminal Ser-Lys-Leu (SKL)
(17), can also direct heterologous proteins to the trypanosome
glycosome (47). However, mutational analysis has established
that considerably more variation in the signal is tolerated for
efficient glycosomal targeting in Trypanosoma brucei than for
peroxisomal targeting (47). Several glycosomal proteins contain an SKL sequence, or one closely related to it, at their
carboxy termini (46), and some of these have been demonstrated to function in glycosomal targeting (7, 48, 49). The
functional relationship of type 2 targeting signals is less clear,
as there are conflicting reports as to whether the type 2 peroxisomal targeting signal is capable of directing proteins to the
glycosome (6, 49). However, the type 2 peroxisomal targeting
motif is similar to one that directs an endogenous protein to
glycosomes (6).
Until now, nothing was known about the genes involved in
glycosomal biogenesis and their relationships to peroxisome
biogenesis genes, due in part to the inability to generate stable

Glycosomes are organelles found only in the kinetoplastid
protozoa (33, 34), which includes the trypanosomatid pathogens
causing sleeping sickness (African trypanosomes), Chagas’ disease (American trypanosomes), and leishmaniasis (Leishmania spp.). The glycosome compartmentalizes several important metabolic pathways, including the first six steps of
glycolysis and enzymes involved in purine salvage and pyrimidine biosynthesis (33). Glycosomal compartmentalization has been hypothesized to be required for the high
glycolytic rate of African trypanosomes, arguably the highest among all eukaryotes, while devoting less than 10% of
total cellular protein to this pathway (34). In these parasites,
virtually all energy is derived from glycolysis (33). The glycosome is also thought to be the site of the synthesis of the
ether-linked lipids (32), which in Leishmania comprise the
plasma membrane anchor of a major surface virulence determinant, the lipophosphoglycan (LPG) (56). The compartmentalization of these critical metabolic pathways has led to
the consideration of the glycosome as a potential target for
drug development.
Based on its single membrane, dense matrix, and lack of
DNA, the glycosome is categorized as a member of the microbody family of organelles, which also includes the peroxisomes
found in nearly all higher eukaryotes as well as the glyoxysomes

* Corresponding author. Mailing address: Seattle Biomedical Research Institute, 4 Nickerson St., Seattle, WA 98109. Phone: (206)
284-8846, ext. 315. Fax: (206) 284-0313. E-mail: mparsons@u.washington
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glycosome biogenesis mutants. We report here the isolation,
via a positive genetic selection technique, of a Leishmania
donovani cell line defective in efficient glycosomal import
(gim1-1 mutant). This mutant line exhibits an unusual phenotype, not typically seen in peroxisome biogenesis mutants, in
which the defect in glycosomal import is both partial and restricted to specific proteins. Even this limited defect has a
pronounced effect on cellular metabolism, since the normally
abundant lipid storage bodies were almost absent from the
mutant cells. This unexpected alteration demonstrates that the
glycosome plays an important role in Leishmania physiology.
We were able to the identify a Leishmania gene that rescues
the mutant to restore efficient glycosomal import. Interestingly, the encoded protein exhibits overall sequence similarity
to mammalian peroxisome assembly factor 1 (PAF1) (44, 54),
which was recently renamed peroxin 2 (PEX2) (11). It also
possesses the most characteristic motif of these proteins, a
C3HC4 cysteine ring motif near the carboxy terminus (39, 54).
In the mutant strain, one copy of this gene was shown to
contain a premature stop codon. The conservation of a gene
involved in both glycosome and peroxisome biogenesis provides evidence at a new level for the theory that the two
organelles evolved from a common ancestor. Our findings extend the evolutionary antiquity of the PEX2 gene family and
the peroxisome lineage to a time preceding the divergence of
trypanosomatids, one of the most ancient orders of eukaryotes.
MATERIALS AND METHODS
Tissue culture and transfection. Promastigotes of L. donovani 51.1 were used
in all experiments and were maintained in medium 199 (M199; Gibco) supplemented with 5% fetal calf serum (FCS; Atlanta Biochemicals). Log-phase parasites (4 3 107) were transfected by using a Gene Pulser (Bio-Rad) and standard
procedures (26), using 10 to 50 mg of plasmid or cosmid DNA. Transfectants
were grown overnight without selection. The next day, half of the culture was
plated on 0.9% agarose–M199–10% FCS plates containing the appropriate selective agent(s), and the remaining half was grown under selection in liquid
culture. Geneticin (Sigma) was used at 10 mg/ml and hygromycin (Sigma) was
used at 35 mg/ml in both liquid and agarose plate cultures.
Plasmids and cosmids. The pX vector (29), which specifies geneticin resistance, was used to express bleomycin resistance protein (Ble)-luciferase (Luc)
fusion proteins with and without a glycosomal SKL targeting signal. The BLE
coding region was amplified from pUT333 (CAYLA Laboratories), using the
primers 59 BLE (GACGCTCGAGAGGCCTATGGGCGAAATGACCGACCA;
the start codon is underlined, and the sequence of the linker containing XhoI and
StuI recognition sites is italicized) and 39 BLE (GACGAAGCTTGCGCATGA
GATGCCTGCAAGCAA; linker containing a HindIII site is italicized). The
product was cleaved with XhoI and HindIII and subcloned upstream and in
frame with the LUC gene in pBSLUC1 (a gift from C. C. Wang and Jürg
Sommer). This yielded plasmid pXB-L, which encodes a fusion protein consisting of Ble-Cys-Ala-Ser-Leu-Ile-Luc. pXB-LDSKL was constructed in the same
way, by subcloning the BLE gene PCR product upstream and in frame with the
LUC gene in pLUH207 (48), which encodes a Luc lacking the SKL targeting
signal. The targeted and untargeted BLE-LUC genes were excised from their
respective plasmids on StuI-BamHI fragments and subcloned into pX digested
with SmaI and BamHI to yield pXB-L. Sequencing of the BLE-LUC junction
confirmed that the two coding regions were joined in frame. Transfections for
expression of Luc (as a nonfusion protein) used the plasmid PX63HYG, which
specifies hygromycin resistance (10). Similarly, the cosmid backbone used for the
L. donovani genomic DNA library contains the hygromycin resistance gene. This
library has been described previously and is from strain Ld4 (41). Subclones of
the relevant cosmids were made by deletion of restriction fragments followed by
religation or by subcloning specific restriction fragments into pX63HYG.
Selection for glycosome biogenesis defects. The selection scheme was based on
one used to select for peroxisome-deficient yeast strains (12). A related scheme
was proposed for isolating glycosome-deficient T. brucei (9), although stable
mutants have yet to be described. L. donovani cells (109) expressing Ble-Luc
(designated wt/B-L) were mutagenized by exposure to 12 mg of ethyl methanesulfonate per ml for 4 h in 10 ml of medium with shaking. Stringent mutagenesis
(;90% killing) was used to attempt to mutate both alleles. Surviving cells (108)
were allowed to recover for 24 h before the primary selection in 5 ml of medium
containing 600 mg of phleomycin (Sigma) per ml for 2 h. This selection killed
;85% of the cells after 3 days. Once surviving cells had recovered to 108 cells,
secondary selection in 800 mg of phleomycin per ml for 3 h was carried out, and
half of the culture (5 3 107 cells) was immediately plated on 0.9% agarose–
M199–10% FCS plates containing 150 mg of phleomycin per ml. Phleomycin-
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resistant colonies appeared at a rate of approximately 4 3 1025 and were picked
into liquid culture and grown for Luc compartmentalization analysis. Differential
digitonin solubilization was performed as described previously (47), and Luc
activity in pellet and supernatant fractions was measured on a Monolight 2010
luminometer (Analytical Luminescence Laboratory). Since it is likely that many
of the mislocalization mutants obtained are sister clones, it is not possible to
reliably measure the frequency of the desired mutants. However, we estimate
that 1 in 107 to 108 mutagenized cells had the mislocalization phenotype.
Immunoblot analysis. Differential digitonin solubilization was performed on
4 3 107 cells from the unselected wt/B-L cells and the mutant gim1-1/B-L cells
at increasing digitonin concentrations. For hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and glyceraldehyde phosphate dehydrogenase
(GAPDH) immunoblot analysis, pellet and supernatant fractions from 107 cell
equivalents were loaded per lane on sodium dodecyl sulfate–10% polyacrylamide
gels. For Luc, 56PGK (the 56-kDa isozyme of phosphoglycerate kinase), and
ribosomal protein P0 immunoblots, 4 3 106 cell equivalents were loaded per
lane. Immunoblot analysis was done as described previously (36). The antiHGPRT antiserum was a gift from Buddy Ullman, the anti-GAPDH antiserum
was a gift from Paul Michels, and the anti-P0 antiserum (45) was a gift of Steven
Reed and Yasir Skeiky. The anti-56PGK and anti-T. brucei glycosome antisera
have been described elsewhere (36).
Electron microscopy. Promastigotes were collected by centrifugation at
1,000 3 g for 10 min. Pelleted cells were gently resuspended and fixed in 2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 h on ice. Cells
were then washed twice in 2% sucrose in 0.1 M sodium cacodylate, followed by
postfixation for 2 h at 58C in 1% osmium tetroxide–5 mM calcium chloride–0.8%
potassium ferricyanide in 0.1 M sodium cacodylate. Cells were washed twice in
water and stained en bloc in 2% uranyl acetate for 12 h. Following centrifugation,
the pelleted cells were gently resuspended in 100 ml of 2% agarose (SeaPlaque
low-gelling-temperature agarose) in 0.1 M sodium cacodylate. The solidified
agarose was cut into small pieces for subsequent processing. Cells were dehydrated through a graded ethanol series to propylene oxide and infiltrated and
embedded in tEpon-812 (Tousimis). Sections were cut at a thickness of 40 to 70
nm on a Sorvall MT-5000 ultramicrotome with a Diatome diamond knife and
stained in saturated uranyl acetate in 50% ethanol and Sato’s lead stain (42).
Sections were observed and photographed on a Zeiss 109 transmission electron
microscope. For counts of glycosomes and lipid bodies, section areas were selected based only on a high cell density, using magnifications too low to resolve
the organelles of interest. A map of the cells in the area was sketched, and each
cell to be subsequently evaluated was numbered on the map. Each cell was then
video printed at a primary magnification of 37,000 and then studied at a high
magnification (312,000 to 320,000) to determine the number of glycosomes and
lipid bodies for each cell. The lipid bodies were easily identified since they lack
a bounding membrane and have a very regular shape. Glycosomes were identified by virtue of their thin membrane, size, and granular contents. A total of 75
cells was analyzed for each of the wt/B-L, gim 1-1/B-L, and rescued gim111pGIM1 cell lines. A cross grating replica (Polaron Equipment, Bio-Rad) of
known grating dimension was video printed at a magnification of 37,000 and
used to determine the exact total area of all cells analyzed for each cell line.
Rescue of the gim1-1/B-L cell line. The L. donovani cosmid library in cLHYG
was transfected into the gim1-1/B-L cell line, and 1,150 individual hygromycinresistant colonies were grown in 96-well microtiter plates in M199–10% FCS.
After 14 days, a visible button of cells was present in all wells, and the plates were
replica plated into 96-well plates containing 0 or 130 mg of phleomycin per ml.
An eight-well multichannel pipettor was used to inoculate approximately 5 3 103
to 1 3 104 cells into each well. Plates were scored after 7 days for sensitivity to
phleomycin. Eight colonies were identified as possibly phleomycin sensitive and
were then rescued from the master plate and retested for phleomycin sensitivity.
Two of the 1,150 original transfectants passed this second screen and were
hypothesized to contain a cosmid restoring normal glycosomal import. Cosmids
were isolated and transformed into Escherichia coli. Restriction mapping of
genomic cosmid inserts was performed by using partial restriction digestion
followed by Southern blotting using end-labeled T3 or T7 primers as probe.
RNA and DNA analyses. RNA blot analysis was performed as previously
described (37), using 5 mg of total RNA isolated from wild-type and gim1-1/B-L
cells and separated on a 1.5% agarose formaldehyde gel. Samples of genomic
DNA isolated from wild-type and gim1-1/B-L cells were digested with various
restriction enzymes. The fragments were separated on a 0.85% agarose gel,
blotted to Nytran (Schleicher & Schuell), and hybridized. Riboprobes for both
RNA and DNA blots were synthesized from pBSGIM1, which is a pBluescript
(Stratagene) subclone of the 1.3-kb NdeI-XhoI fragment containing GIM1. Final
stringencies were 0.13 SSC (13 SSC is 150 mM NaCl plus 15 mM sodium
citrate) at 658C.
DNA sequencing. Both strands of the pGIM1 insert were sequenced by using
a combination of nested deletion (22), random sequencing, and primer walking.
DNA sequencing was on an ABI automated sequencer using ABI dye terminator
cycle sequencing (Applied Biosystems, Foster City, Calif.). The entire coding
region of GIM1, plus approximately 300 bp flanking sequence on either side, was
amplified from both wild-type and gim1-1 cells, using the high-fidelity polymerase
PfuI (Stratagene). The products were cloned into pBluescript and sequenced.
Independently generated PCR products were directly sequenced to verify the
presence or absence of the identified mutation in both cell types.
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FIG. 1. Efficiency of phleomycin selection on L. donovani cell lines expressing Ble-Luc compared to a cell line expressing untargeted Ble-LucDSKL. Stably
transfected cells (3 3 106) were exposed to phleomycin (600 mg/ml) for 2 h,
washed, and grown in fresh M199. For comparison, growth of wild-type cells in
nonselective medium is shown. (No obvious differences were noted between the
lines in nonselective medium.) Cells were counted at 24-h intervals.
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FIG. 2. The gim1-1/B-L cell line mislocalizes Ble-Luc fusion protein to the
cytosol. Cells from the indicated cell lines were fractionated into organellar pellet
and cytosolic supernatant fractions following differential digitonin solubilization
of the plasma membrane. The percentage of Luc activity present in the cytosolic
fraction is shown. The bar marked wt/B-L 28 indicates wild-type cells transfected
with pXB-L isolated from the gim1-1/B-L cell line.

Nucleotide sequence accession number. The nucleotide sequence of the
pBSGIM1 insert has been deposited in GenBank with accession number U80074.

RESULTS
Isolation of a glycosome-defective cell line. It has proven
possible to isolate loss-of-function mutants of Leishmania by
mutagenesis and appropriate selections (24, 25, 27). The identification of Leishmania cell lines defective in glycosome biogenesis presents several challenges not faced in the isolation of
yeast peroxisome-deficient cell lines. First, in contrast to yeast,
Leishmania is diploid and there is no experimentally manipulable sexual cycle. Second, unlike peroxisome-deficient yeast,
glycosome-deficient Leishmania may not be viable. Third, due
to differences between yeast and trypanosomatid metabolism,
the metabolic selection strategies used to identify peroxisomedeficient yeast (13, 18, 58, 60) would be unlikely to yield mutants defective in glycosome biogenesis or import. To address
the last two concerns, we adopted a selection scheme based on
a positive selection for mutants defective in protein import
(12). This protocol made no assumptions about metabolic roles
and additionally could yield mutants only partially defective in
glycosomal compartmentalization.
The starting cells were L. donovani promastigotes stably
transfected with a Leishmania expression vector encoding a
fusion protein consisting of Ble (15), which specifies phleomycin resistance, fused to the amino terminus of luciferase (Luc)
which contains a C-terminal SKL glycosomal targeting signal.
The specificity of this signal is well established (47). The plasmid and clonal line are designated pXB-L and wt/B-L, respectively. If the Ble-Luc fusion protein is sequestered in the glycosome, it should be unable to bind the selective agent
phleomycin. Thus, phleomycin selection will kill cells with intact glycosomal import. In cells with defects in glycosomal
import, Ble-Luc would remain partially or completely cytoplasmic and could bind phleomycin, thus preventing its cytotoxic
action. Such cells should survive phleomycin selection. Figure
1 verifies the effectiveness of phleomycin selection on wt/B-L
cells. Wild-type cells expressing a cytosolic Ble-LucDSKL fu-

sion protein were resistant and grew well even at high concentrations of phleomycin.
We mutagenized wt/B-L cells and selected with phleomycin.
Numerous colonies arose which were then examined to determine if any had mislocalized Ble-Luc to the cytoplasm. Subcellular fractionation was carried out by using differential digitonin solubilization. At low digitonin concentrations, the
glycosomal membrane remains intact due to its low cholesterol
content, while the plasma membrane is solubilized, releasing
cytosolic proteins (43). Following subcellular fractionation,
Luc assays were performed to differentiate clones with Luc
mislocalized to the cytosol from the majority of clones that
displayed normal Luc targeting. Of 120 colonies tested, 5
showed evidence of mislocalization. As these were not necessarily independent, we concentrated on the clone gim1-1/B-L
in which 50% of the Luc activity was cytosolic (Fig. 2). In
comparison, in wild-type cells, Ble-Luc cofractionates with the
glycosome-containing organellar pellet, while Ble-LucDSKL is
localized almost exclusively to the cytosolic fraction.
We next ruled out several trivial explanations for the mislocalization phenotype. To investigate the possibility that a plasmid-borne defect could explain the cytosolic fusion protein,
pXB-L was reisolated from the gim1-1/B-L clone and transfected into wild-type cells. As seen in Fig. 2, the retransfected
plasmid specified a fusion protein that cofractionated with the
organellar pellet, with little remaining in the cytosol. To address the chance that an overall increase in fusion protein
expression might overwhelm the glycosomal import pathways,
immunoblot analysis was performed to compare fusion protein
expression in unselected cells with expression in the gim1-1/
B-L cell line. No significant difference in fusion protein expression was observed (Fig. 3, LUC). No differences in plasmid
copy number or plasmid structure were detected between the
gim1-1/B-L and wt/B-L clones (data not shown). The mislocalization defect in the gim1-1/B-L clone is therefore a cell-specific defect affecting the import of at least one protein into
glycosomes.
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FIG. 3. Distribution of glycosomal proteins in the gim1-1/B-L cell line. Increasing amounts of digitonin (indicated in micrograms per milliliter) were used
to solubilize wt/B-L (wt) and gim1-1/B-L (Gim1-1) cells. Aliquots of the organellar pellet (P) and cytosolic supernatant (S) fractions were separated on sodium
dodecyl sulfate–10% polyacrylamide gels and immunoblotted with the indicated
antibodies. For the LUC panel, wild-type and gim1-1/B-L cells expressing the
Ble-Luc fusion protein plus a Luc nonfusion protein were used (both of these
contain a C-terminal SKL targeting signal). The solid arrow indicates the 81-kDa
Ble-Luc fusion protein; the open arrow indicates the 67-kDa Luc. In the 56PGK
panel, the solid arrow indicates the 56-kDa minor glycosomal isozyme, and the
open arrow points to the region where both the cytosolic and the second glycosomal phosphoglycerate kinase isozyme are expected to migrate. On staining, the
lane containing the 50-mg/ml supernatant fraction for gim1-1/B-L in the P0 panel
was found to be overloaded in comparison with the same lane in the wt/B-L
panel. Positions of protein standards are shown in kilodaltons.

The gim1-1 mutant has few lipid bodies and mislocalizes a
subset of glycosomal proteins. The properties of gim1-1 were
further explored by analyses of protein compartmentalization
and ultrastructure. Western blot analysis was used to evaluate
the localization of other glycosomal proteins. wt/B-L and gim11/B-L cells were solubilized with increasing concentrations of
digitonin prior to subcellular fractionation. Figure 3 demonstrates that a subset of proteins was localized to the cytosol to
a much greater extent in the gim1-1/B-L cell line than in the
original parental cell line. These include the Ble-Luc fusion
protein (solid arrow) and a Luc nonfusion protein (which contains an SKL signal) which was expressed from a second plasmid transfected into the two cell lines. Similarly, the glycosomal enzyme HGPRT (2) was inefficiently compartmentalized.
This result further confirms that the defect in the gim1-1/B-L
cell line is cell specific and affects localization of some proteins
normally found within the glycosome. In contrast, other proteins appear to be compartmentalized normally. At digitonin
concentrations that release cytosolic proteins such as the ribosomal protein P0, both GAPDH and the 56PGK remained in
the organellar pellet in gim1-1/B-L cells and wt/B-L cells. (Also
marked in the PGK immunoblot is the location of other phosphoglycerate kinase isozymes, hypothesized by analogy to
other trypanosomatids [35, 36] to be a mixture of cytosolic and
glycosomal forms.) GAPDH and 56PGK therefore appeared t
be efficiently localized in gim1-1/B-L cells. Further studies using an antibody raised against T. brucei glycosomes, which
detects at least eight proteins of unknown identity in Leishmania, suggested that almost all glycosomal proteins were similarly compartmentalized in wild-type and mutant cells, since
only one of the proteins detected was apparently mislocalized
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(data not shown). Taken together, this evidence demonstrates
that gim1-1/B-L is a leaky mutant and is probably still capable
of assembling glycosomes which contain at least a substantial
complement of glycosomal proteins.
Electron microscopic analysis of wt/B-L, gim1-1/B-L, and the
rescued gim1-1/B-L cell lines (see below) demonstrated that
most cellular structures appeared identical in all three cell lines
(Fig. 4). As predicted from the glycosomal protein targeting
data, glycosomes were seen distributed throughout the cytoplasm in all cell lines (Fig. 4A to C). No major differences in
glycosome morphology or number were apparent, with 17 glycosomes per 100 mm2 for wild-type cells and 19 per 100 mm2
for gim1-1/B-L cells. Unexpectedly, these analyses demonstrated an approximately 10-fold decrease in the number of
lipid bodies in gim1-1/B-L cells (0.9 per 100 mm2) relative to
wt/B-L cells (7.8 per 100 mm2). These lipid bodies have been
postulated to serve as an energy reserve (30).
Rescue of gim1-1 identifies a gene related to human PEX2. A
functional rescue approach was used to screen a wild-type L.
donovani genomic DNA cosmid library for sequences that restore efficient glycosomal targeting to the gim1-1/B-L mutant
cell line. Rescue of the mislocalization defect in the gim1-1/B-L
cell line renders the cells phleomycin sensitive by virtue of the
restoration of efficient glycosomal import of the Ble-Luc fusion
protein. Briefly, the gim1-1/B-L mutant was transfected with a
genomic library cloned into the cLHYG Leishmania cosmid
shuttle vector (41). Individual hygromycin-resistant clones
were grown in liquid culture and replica plated into media with
and without phleomycin. Of 1,150 independent transfectants
tested, two clones which were reproducibly phleomycin sensitive were identified. Analysis of Ble-Luc compartmentalization
showed the wild-type pattern, with little fusion protein remaining in the cytoplasm (Fig. 5A). This result indicated that glycosomal targeting was restored in these clones. To confirm that
the rescue was cosmid mediated and not the result of a reversion, the cosmids isolated from the two phleomycin-resistant
clones were retransfected into gim1-1/B-L cells. The resultant
lines were tested for phleomycin resistance and Luc compartmentalization. In contrast to an irrelevant cosmid, both of
these cosmids (designated cGIM1A and cGIM1B) restored the
wild-type phenotype of phleomycin sensitivity and Ble-Luc targeting to the organellar pellet (Fig. 5A). Thus, the cosmids
each carry a gene that allowed this functional rescue.
Restriction mapping of cGIM1A and cGIM1B revealed that
they shared a common region (Fig. 5B). To further map the
gene (or genes) that rescued the gim1-1 phenotype, we tested
various deletion clones of the cosmids for the ability to restore
import. A 6-kb segment rescued Ble-Luc import (Fig. 5, clone
cGim1BD3), and random fragments within this region were
sequenced. BlastX searches (3, 16) of the sequences identified
a region specifying an amino acid sequence with homology to
human PEX2, previously known as PAF1, and homologous
yeast proteins that have been identified as being required for
peroxisome biogenesis in higher eukaryotes. A 1.3-kb XhoINdeI DNA fragment containing the corresponding open reading frame was subcloned into the expression vector pX63HYG
to yield pGIM1. This plasmid fully restored normal targeting
of the Ble-Luc fusion protein when transfected into gim1-1/B-L
cells. It also restored the high numbers of lipid bodies to the
parasites (13.4 per 100 mm2 in gim1-1/B-L1pGIM1 cells versus
0.9 per 100 mm2 in gim1-1/B-L cells). The number of glycosomes per unit area was slightly less than in wild-type cells (12
versus 17 per 100 mm2).
The DNA sequence of the pGIM1 insert reveals an open
reading frame of 990 bp encoding a polypeptide of 330 amino
acids with a calculated molecular mass of 38 kDa. Like other
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FIG. 4. Electron micrographs of wt/B-L (A and D), gim1-1/B-L (B and E), and rescued gim1-1/B-L (C and F) cells. Representative organelles are labeled: g,
glycosomes; l, lipid bodies; m, mitochondrion. Panels on the left show a section through the cells. Panels on the right show enlargements of glycosomes marked with
arrowheads in cells on the left. The mitochondria and glycosomes in panels B and E appear darker because the section was thicker and stained well. Left panels, bar 5
1 mm; right panels, bar 5 200 nm.

glycosomal proteins, including the two integral membrane proteins characterized previously (38), Gim1 is very basic, with an
isoelectric point of 9.67. As shown in Fig. 5, Gim1 has significant homology with the human peroxisomal integral membrane protein PEX2 (PAF1) (44), with 27% identity and 55%
similarity at corresponding residues. Gim1 is also related to the
proposed PEX2 homologs from the yeast Pichia pastoris (59)
(Per6p; 28% identity and 57% similarity) and the filamentous
fungus Podospora anserina (5) (car1; 23% identity and 54%
similarity), all of which are known to be required for peroxisome biogenesis in their respective organisms. This level of
relatedness is comparable to that of human and fungal proteins
(;27% identity). In addition to the overall amino acid similarity, a C3HC4 cysteine ring motif in the carboxy-terminal half
of Gim1 aligns with the C3HC4 motif of the PEX2 proteins
(though car1 contains several insertions in this region). This
motif is hypothesized to be involved in protein-protein interactions (14, 55). Gim1 is slightly shorter than human PEX2 and
possesses a 24-residue amino-terminal extension relative to all
known PEX2 family proteins except car1, which has an unrelated amino-terminal extension (Fig. 6).

To determine if GIM1 complements the primary lesion or
acts as a suppressor, we performed additional analyses of
GIM1 transcripts and genes. Northern blot analysis using the
GIM1 gene detected a 1.4-kb GIM1 transcript at similar levels
in both wt/B-L and gim1-1/B-L cells (Fig. 7A). Southern analysis using multiple restriction enzymes, including those shown
in Fig. 7B, indicates that GIM1 is a single-copy gene. No
obvious alterations such as large insertions, deletions, or rearrangements were detected. We then amplified, cloned, and
sequenced both alleles from the gim1-1/BL strain. One allele
contained a point mutation that converted a glutamine codon
(CAA) to a stop codon (TAA) at amino acid 240 (Fig. 6). This
mutation would truncate the protein prior to the cysteine ring
motif. The second allele was identical to that of the parent
wild-type strain and the cosmid throughout the coding region.
An additional 230 bp of flanking sequence on either side of the
gene was analyzed, and no changes were observed. The presence of this mutation in one allele of the mutant line and its
absence from the wild-type parent were verified by direct sequencing of independent PCR products.
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FIG. 5. The GIM1 gene rescues the gim1-1/B-L cell line. (A) Compartmentalization of Ble-Luc, as determined by Luc activity. Bars are shaded according
to the phleomycin sensitivity of the cells line (r, resistant; s, sensitive). All lines
contain pXB-L. Any additional plasmids or cosmids that they contain are indicated, with cB7 being an irrelevant, random cosmid. 18 transfectants are those
arising after transfection with the cosmid library; 28 transfectants are those
transfected with cosmid DNA isolated from the primary clone. (B) Restriction
maps and relative positions of cosmid inserts cGim1A and cGim1B are shown at
top; the deletion constructs used in rescue studies are shown below. Cytosolic
Luc activity determinations for gim1-1/B-L cell clones arising following transfection with each deletion construct are shown at the right. The box represents the
GIM1 coding region, and the arrow designates the direction of transcription. A,
ApaI; B, BglII; N, NsiI; D, NdeI; S, SmaI; F, SfiI; X, XhoI.

DISCUSSION
This report describes the isolation of an L. donovani cell line
with a defect in efficient import of proteins targeted to the
glycosome and the identification of the GIM1 gene that rescues
the defect. The product of the GIM1 gene, Gim1, shares substantial amino acid sequence similarity with the PEX2 family
of proteins from humans and yeast, all of which are peroxisomal integral membrane proteins known to be required for

MOL. CELL. BIOL.

peroxisome biogenesis. This represents the first identification
of a gene involved in glycosomal biogenesis.
The results of this study support the view that peroxisomes
and glycosomes have a common evolutionary origin. The similarity in protein targeting signals, the partial overlap in metabolic pathways, and now conservation of a gene involved in
biogenesis all point to a common ancestor for all microbody
organelles. Since kinetoplastids are the first organisms on the
evolutionary tree to possess these unique organelles, we can
speculate that the endosymbiotic event giving rise to extant
microbodies may have occurred after the separation of the
most divergent eukaryotes, such as Giardia, Microsporidia, and
Trichomonas. Kinetoplastids are also the first mitochondriate
organisms, suggesting that the acquisition of the progenitors of
both mitochondria and microbodies could have occurred at
similar points in the evolution of eukaryotes.
Although the absence of peroxisomes has a devastating effect on human development (affecting the function of brain,
liver, and kidney and leading to perinatal death), peroxisomes
are not required for cellular viability. Thus, it has been possible
to identify numerous mutants with peroxisome biogenesis defects by using selection and screening strategies focused on the
loss of a peroxisomal metabolic pathway. However, the different metabolic role of glycosomes suggested that they might be
essential in Leishmania, and we therefore chose a positive
selection strategy that did not require the loss of metabolic
functions. We do not know whether only mutants with partial
defects in glycosome biogenesis are viable, and future studies
seeking new gim mutants will provide the answer to this question. Although leaky mutants are often not considered useful
for isolating complementing genes, we were able to use the
gim1-1 mutant to isolate the GIM1 gene.
The function of PEX2 is unknown. Its localization within the
peroxisomal membrane and its conserved cysteine ring motif
have led to speculation that PEX2 homologs are involved in
protein translocation into the microbody matrix (59). PEX2
gene defects are one cause of the fatal human peroxisomal
disorder Zellweger’s syndrome (44). Mutants in PEX2 family
genes described thus far are defective in the import of all
peroxisomal proteins examined (44, 54, 59) (although a Pichia
mutant is slightly leaky). In contrast, the gim1-1 mutant mislocalizes to the cytosol only a subset of proteins with the type
1 signal. These include the marker enzyme Luc, which has a
C-terminal SKL, and HGPRT, with a C-terminal SKV (2).
Curiously, another type 1 protein, GAPDH (2SKM, as found
in the Leishmania mexicana gene [20]), as well as 56PGK, a
protein predicted by analogy with the trypanosome (1) and
Crithidia fasciculata (51) homologs to lack a type 1 or 2 signal,
are efficiently imported into the organellar pellet. Perhaps
most similar to the gim1-1 phenotype in this respect is the pex5
(pay32) mutant of the yeast Yarrowia lipolytica. In this mutant,
some type 1 peroxisomal proteins remain in the cytoplasm while
others cofractionate with peroxisomes, apparently trapped as
translocation intermediates (52). Since PEX5 is not homologous to GIM1, it is clear that defects in a variety of genes could
lead to a partial defect in organelle biogenesis. It will be interesting to determine how the gim1-1 defect allows some type
1 proteins entry into the glycosome while others remain in the
cytosol. It is possible to envision that competition at the glycosome membrane for scarce intact import machinery causes a
significant amount of proteins with weak glycosomal targeting
signals to remain unimported in the cytosol.
The presence of a mutant allele, gim1-1, in the mutant strain
strongly supports the hypothesis that GIM1 rescues by virtue of
complementation of the initial lesion. The presence of both
wild-type and mutant alleles in the gim1-1 strain suggests that
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FIG. 6. Comparison of the amino acid sequences deduced from the L. donovani GIM1 gene and other genes in the PAF gene family. Sequences shown: Gim1, L.
donovani; PAF1, human PEX2; car1, Podospora anserina PEX2; Per6p, Pichia pastoris PEX2. Black shading indicates identity with Gim1, and gray shading indicates
similarity. Open circles mark the cysteines in the C3HC4 ring motif; asterisks designate stop codons. The location of the premature stop codon found in the gim1-1
mutant allele is marked by an arrow. Only the domains homologous to Gim1 are shown; car1 and Per6p extend another 98 and 82 amino acids, respectively.

the mutant allele may behave as a dominant negative mutation
with respect to the phenotype that we observed. If, as hypothesized, PEX2 homologs are involved in protein-protein interactions, a defective Gim1 protein could result in nonproductive
interactions yielding a dominant negative phenotype. Another
alternative is that the gim1-1 phenotype is simply the result of
a gene dosage effect. In either case, the presence of a wild-type
allele may account for the restricted nature of the import
defect. Although not common, dominant negative alleles for
two genes involved in peroxisome biogenesis have been described (53). Interestingly these dominant negative alleles yield
a peroxisome import defect when present with a wild-type
allele in diploid cells of the yeast Hansenula polymorpha but
peroxisome deficiency when alone in haploids. In the future,
we will attempt to disrupt GIM1 in order to definitively characterize its role in glycosome biogenesis and to generate a true
glycosome-deficient Leishmania cell line. Although disruption
of critical genes is still more difficult in trypanosomatids than in
organisms such as yeast (due to the lack of a sexual segregation
system, the slow growth and ploidy of the parasite, and the
paucity of strategies for manipulating gene expression), such
studies will be important because they will allow us to further
explore the role of the glycosome in parasite virulence and
viability.
Our observations on the phenotype of the mutant, which
exhibits only very restricted defects in protein import, provide
preliminary support for the theory that glycosomes are critical
organelles. We observed a dramatic decrease in the number of
lipid bodies in gim1-1 cells compared to wild-type cells. Rescue
with the GIM1 gene restored high numbers of lipid bodies. We
can pose several possible explanations for this finding. The first
is that Gim1 has pleiotropic functions and independently af-

fects both glycosomes and lipid bodies. Another explanation
could be that disruption of glycolysis caused by the mislocalization of one or more glycolytic enzymes to the cytosol may
force gim1-1 cells to utilize their lipid reserves as an energy
source. Finally, glycosomally located ether-lipid biosynthesis
could be disrupted, negatively affecting the biosynthesis of lipid
bodies more directly. It is known from studies of patient’s with
Zellweger’s syndrome that while some peroxisomal proteins
are stable and functional when mislocalized to the cytosol,
some, including enzymes of ether lipid synthesis, are not (23).
An issue of great potential interest is the biosynthesis of an
important surface glycolipid, LPG, which is anchored to the
membrane by a lyso-alkyl-ether-lipid. LPG has been implicated
in several critical roles in the Leishmania infectious cycle (57).
Disruption of ether-lipid synthesis in the glycosome in gim1-1,
as suggested by the lack of lipid bodies, might have significant
effects on the expression of LPG and parasite virulence. The
diversity of pathways contained within the glycosome, combined with the possibility of isolating mutants with highly restricted defects, as described here, suggests that the analysis of
glycosome biogenesis mutants will provide new insights into
the functional role of subcellular compartmentalization.
Leishmania parasites cause mucocutaneous, cutaneous, and
visceral infections, killing approximately 400,000 of the 367
million people at risk each year (4). No effective vaccines
against this group of organisms are currently available, and
treatment generally involves use of toxic compounds. Drug
discovery is therefore of major importance, and the glycosome
stands out as a potential new drug target (31, 50). It seems
likely that the ability to inhibit the import of glycosomal proteins would prove deleterious to the parasite. Even preventing
the import of a subset of glycosomal proteins would likely be
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FIG. 7. The GIM1 gene encodes a 1.7-kb transcript and is a single-copy gene.
(A) Northern analysis. Total RNA (5 mg) from wild-type (wt) and gim1-1/B-L
(gim1-1) cells was separated on a formaldehyde-agarose gel, transferred to a
filter, and hybridized with an antisense riboprobe from pBSGIM1. RNA size
markers are shown at the right. (B) Southern analysis. Genomic DNA (6 mg)
from wild-type and gim1-1/B-L cells was digested with BglII or XhoI and separated on a 0.85% agarose gel, transferred to a filter, and hybridized with an
antisense riboprobe from pBSGIM1. In each cell line, the probe hybridizes to a
single band which comigrates with control cGim1A cosmid cut with the same
enzyme. DNA size markers are shown at the right.

toxic since it would effectively segregate enzymes within a metabolic pathway into different subcellular compartments.
Whether specific inhibitors of Gim1 function could be developed awaits further study, but given the rather moderate similarity of Gim1 and human PEX2, it seems likely that structural
differences in biogenesis proteins could be exploited for drug
development.
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